As AstraZeneca Admits to New Side Effects, Should People With Covishield Vaccines Worry? – The Weather Channel

A healthcare worker readies a COVID-19 vaccine for administration at a public healthcare centre in Navi Mumbai, Maharashtra.

Concerns over the Covishield vaccine's potential side effects have sparked debates once again, amidst the ongoing backdrop of the coronavirus pandemic. Let's delve into the intricacies of this controversy and decipher whether there's genuine cause for alarm.

Following his vaccination with the AstraZeneca COVID-19 vaccine, Jamie Scott's life took a tumultuous turn. He grappled with a brain clot and severe bleeding, leaving him with permanent brain damage. This rare condition, labelled Thrombosis with Thrombocytopenia Syndrome (TTS), poses a significant threat due to its potential to cause dangerously low blood clot and platelet levels. Jamie's plight, accompanied by memory loss, impaired vision, and cognitive decline, prompted him to seek legal recourse against the pharmaceutical giant in 2023.

Jamie's legal team contends that AstraZeneca downplayed the potential risks associated with their vaccines. Disturbingly, reports suggest that over 50 vaccinated individuals suffered similar adverse effects, some tragically resulting in fatalities or severe injuries. Despite vehement denials from the pharmaceutical company, subsequent legal proceedings unveiled a startling admission: AstraZeneca acknowledged the vaccine's rare propensity to cause TTS, although the exact mechanism remains elusive.

In essence, not quite. While scientific links between the AstraZeneca vaccine and vaccine-induced immune TTS have been established, such occurrences are exceedingly rare merely a handful of reported cases amidst millions of administered doses. The World Health Organization has, in fact, reaffirmed the vaccine's safety and efficacy for individuals aged 18 and above. Moreover, it's essential to recognise that contracting COVID-19 itself elevates the risk of blood clots and other complications, whereas vaccination offers protection.

Furthermore, the telltale signs of TTS ranging from headaches to leg swelling typically manifest within 1-6 weeks post-vaccination. Considering that most individuals received their Covishield jabs a couple of years ago, there's little reason for immediate panic.

While there's no definitive evidence favouring one vaccine over another, each comes with its own set of potential side effects. Covaxin, for instance, boasts higher efficacy rates and robust research data among Indian subjects. Nevertheless, it's noteworthy that several countries have suspended the AstraZeneca vaccine's administration due to clotting concerns in specific age groups.

Ultimately, these vaccines have been instrumental in saving countless lives, underscoring the importance of continued vaccination efforts. As we navigate through these uncertain times, it's crucial to heed the guidance of health authorities and make informed decisions for the collective well-being.

**

For weather, science, space, and COVID-19 updates on the go, download The Weather Channel App (on Android and iOS store). It's free!

Read the rest here:

As AstraZeneca Admits to New Side Effects, Should People With Covishield Vaccines Worry? - The Weather Channel